SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
(Amendment No. 1)
Hemagen Diagnostics, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
423501 105
- --------------------------------------------------------------------------------
(CUSIP Number)
Mark A. Weiss, Esq.
Keating, Muething & Klekamp
One East Fourth Street, 18th Floor
Cincinnati, Ohio 45202
(513) 579-6411
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
July 7, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [ ].
(Continued on the following pages)
<PAGE>
CUSIP No. 423501 105 13D Page 2 of 8 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Jerry L. Ruyan
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States citizen
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES ---------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 684,854 - See Item 5(I)(b)
REPORTING ---------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
345,154 - See Item 5(I)(b)
---------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
684,854 - See Item 5(I)(a)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 423501 105 13D Page 3 of 8 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
William P. Hales
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States citizen
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES ---------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 684,854 - See Item 5(II)(b)
REPORTING ---------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
249,600 - See Item 5(II)(b)
---------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
684,854 - See Item 5(II)(a)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
<PAGE>
CUSIP No. 423501 105 13D Page 4 of 8 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Thomas A. Donelan
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States citizen
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES ---------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 684,854 - See Item 5(III)(b)
REPORTING ---------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
50,100
---------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
684,854 - See Item 5(III)(a)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 423501 105 13D Page 5 of 8 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Christopher P. Hendy
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States citizen
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF -0-
SHARES ---------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 684,854 - See Item 5(IV)(b)
REPORTING ---------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
40,000
---------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
684,854 - See Item 5(IV)(a)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
This Amendment No. 1 to Schedule 13D is being filed solely to amend Items 4
and 5.
Item 4. Purpose of Transaction.
Mr. Ruyan resigned as a director of Meridian Diagnostics, Inc.
effective as of July 7, 1999.
Item 5. Interest in Securities of Issuer.
I. Jerry L. Ruyan
(a) See page 2, nos. 11 and 13. No. 11 includes 122,227 warrants
to purchase Common Stock, all of which are currently
exercisable.
(b) See page 2, nos. 7-10. No. 8 includes 122,227 warrants to
purchase Common Stock. No. 9 includes 72,727 warrants to
purchase Common Stock. All such warrants are currently
exercisable.
(c) The following market transactions are all trades involving
the Common Stock made in the last 60 days that were not
previously reported:
Purchase Number Price
Date or Sale of Shares Per Share
---- -------- --------- ---------
6/29/99 Purchase 3,000 $1.38
(d) None.
(e) Not Applicable.
II. William P. Hales
(a) See page 3, nos. 11 and 13. No. 11 includes 122,227 warrants
to purchase Common Stock, all of which are currently
exercisable.
(b) See page 3, nos. 7-10. No. 8 includes 122,227 warrants to
purchase Common Stock. No. 9 includes 49,500 Warrants to
purchase Common Stock. All such warrants are currently
exercisable.
(c) All trades in the Common Stock in the last 60 days were
previously reported.
(d) None.
(e) Not Applicable.
III. Thomas A. Donelan
(a) See page 4, nos. 11 and 13. No. 11 includes 122,227 warrants
to purchase Common Stock, all of which are currently
exercisable.
(b) See page 4, nos. 7-10. No. 8 includes 122,227 warrants to
purchase Common Stock, all of which are currently
exercisable.
(c) The following market transactions are all trades involving
the Common Stock made in the last 60 days that were not
previously reported:
<PAGE>
Purchase Number Price
Date or Sale of Shares Per Share
---- -------- --------- ---------
6/28/99 Purchase 25,000 $1.38
6/29/99 Purchase 25,000 1.38
(d) None.
(e) Not Applicable.
IV. Christopher P. Hendy
(a) See page 5, nos. 11 and 13. No. 11 includes 122,227 warrants
to purchase Common Stock, all of which are currently
exercisable.
(b) See page 5, nos. 7-10. No. 8 includes 122,227 warrants to
purchase Common Stock, all of which are currently
exercisable.
(c) The following market transactions are all trades involving
the Common Stock made in the last 60 days that were not
previously reported:
Purchase Number Price
Date or Sale of Shares Per Share
---- -------- --------- ---------
6/29/99 Purchase 3,500 $1.31
7/1/99 Purchase 5,000 1.25
(d) None.
(e) Not Applicable.
V. Messrs. Ruyan, Hales, Donelan and Hendy
(a) 684,854 shares or 8.7%. Includes 122,227 warrants to
purchase Common Stock, all of which are currently
exercisable.
(b) See pages 2 -5, nos. 7-10. Items 8 and 11 include warrants
to purchase 122,227 shares of Common Stock, all of which are
currently exercisable.
(c) See (I)(c), (II)(c), III(c) and IV(c) above.
(d) None.
(e) Not Applicable.
Dated: July 12, 1999 *
---------------------------
Jerry L. Ruyan
*
---------------------------
William P. Hales
*
---------------------------
Thomas A. Donelan
*
---------------------------
Christopher P. Hendy
*By: /s/Mark A. Weiss
---------------------------
Mark A. Weiss
Attorney-in-Fact
